IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

CHI Advisors LLC

Q3 2021 Holdings

Filed 2021-11-15 | 19 holdings | $51.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cullinan Oncology Inc(CGEM)COM230031106$50.7M2,244,84197.9%
Corvus Pharmaceuticals Inc(CRVS)COM221015100$803.0K165,9271.6%
Prometheus Biosciences IncCOM74349U108$67.9K2,862,0590.1%
Repare Therapeutics Inc(RPTX)COM760273102$58.6K2,232,7830.1%
Pliant Therapeutics Inc(PLRX)COM729139105$41.9K2,484,7240.1%
Vectivbio Hldg AGORD SHSH9060V101$20.0K2,592,6020.0%
Omega Therapeutics IncCOMMON STOCK68217N105$19.9K1,055,8820.0%
Larimar Therapeutics Inc(LRMR)COM517125100$17.5K1,515,1480.0%
Oncorus IncCOM68236R103$16.4K1,755,9790.0%
Inozyme Pharma IncCOM45790W108$10.7K920,2640.0%
Akouos IncCOM00973J101$10.0K858,0270.0%
Orchard Therapeutics PLCADS68570P101$9.4K4,081,9720.0%
Precision Biosciences IncCOM74019P108$7.5K646,7290.0%
Freeline Therapeutics HldgsSPONSORED ADS35655L107$4.9K1,427,4810.0%
Ikena Oncology IncCOM45175G108$4.0K315,0000.0%
Ovid Therapeutics Inc(OVID)COM690469101$785233,5100.0%
G1 Therapeutics Inc(GTHXEUR)COM3621LQ109$67150,0000.0%
Kezar Life Sciences IncCOM49372L100$64875,0000.0%
Keros Therapeutics Inc(KROS)COM492327101$50012,6270.0%